Bispecific Antibodies— Companies & Signals
Bispecific antibodies are engineered proteins that simultaneously bind to two distinct targets, enabling novel therapeutic mechanisms like redirecting immune cells to attack cancer. This innovative approach offers the potential for enhanced efficacy and broader applicability across various diseases, making it a significant area of investment in biotechnology. 54 public companies above the $50M floor. Last 90 days: 26 red 8-Ks, 0 insider cluster-buys, 4 running hot in the press.
54
Companies
26
Red 8-Ks · 90d
0
Insider clusters
4
🔥 Media-hot
Companies in Bispecific Antibodies
Refine in search →| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LYEL | Lyell Immunopharma, Inc. | Healthcare | $315.0M | +9.8% | +6.5% | 200K | — | |
| 2 | CMPX | Compass Therapeutics, Inc. | Healthcare | $365.6M | +3.9% | +2.9% | 2.8M | — | |
| 3 | JANX | Janux Therapeutics, Inc. | Healthcare | $826.9M | +2.6% | +6.9% | 1.2M | — | red 8-K |
| 4 | IBIO | iBio, Inc. | Healthcare | $84.0M | +3.6% | -0.6% | 1.1M | — | red 8-K |
| 5 | ZYME | Zymeworks Inc. | Healthcare | $1.7B | -0.2% | +3.6% | 1.1M | — | |
| 6 | AZN | ASTRAZENECA PLC | Healthcare | $277.2B | +1.4% | +8.2% | 1.6M | 🔥 | |
| 7 | CTMX | CytomX Therapeutics, Inc. | Healthcare | $655.3M | +10.0% | +23.0% | 7.0M | — | red 8-K |
| 8 | CAI | Caris Life Sciences, Inc. | Healthcare | $5.1B | -1.0% | +5.8% | 3.8M | — | |
| 9 | XNCR | Xencor Inc | Healthcare | $914.2M | +3.6% | +11.3% | 750K | — | red 8-K |
| 10 | MGNX | MACROGENICS INC | Healthcare | $251.7M | +1.0% | +6.1% | 1.4M | — | |
| 11 | GLSI | Greenwich LifeSciences, Inc. | Healthcare | $353.2M | +17.4% | -2.1% | 208K | — | |
| 12 | STRO | SUTRO BIOPHARMA, INC. | Healthcare | $477.2M | +9.3% | +5.7% | 465K | — | |
| 13 | CLYM | Climb Bio, Inc. | Healthcare | $655.1M | +2.1% | +9.7% | 1.2M | — | red 8-K |
| 14 | MOLN | MOLECULAR PARTNERS AG | Healthcare | $154.2M | +4.2% | +0.3% | 9K | — | |
| 15 | KNSA | Kiniksa Pharmaceuticals International, plc | Healthcare | $4.0B | +5.4% | +9.2% | 1.5M | — | red 8-K |
| 16 | ZLAB | Zai Lab Ltd | Healthcare | $1.9B | +2.3% | -0.4% | 945K | — | red 8-K |
| 17 | PTGX | Protagonist Therapeutics, Inc | Healthcare | $7.1B | -0.2% | +5.7% | 740K | — | red 8-K |
| 18 | ZURA | Zura Bio Ltd | Healthcare | $351.1M | +5.2% | +33.1% | 2.5M | — | red 8-K |
| 19 | EXEL | EXELIXIS, INC. | Healthcare | $13.4B | -0.9% | +5.7% | 2.6M | — | red 8-K |
| 20 | ARVN | ARVINAS, INC. | Healthcare | $489.1M | +3.6% | +7.1% | 955K | — | red 8-K |
| 21 | CGEN | COMPUGEN LTD | Healthcare | $193.0M | +3.4% | +4.3% | 257K | — | |
| 22 | DNLI | Denali Therapeutics Inc. | Healthcare | $3.4B | +1.3% | +7.7% | 2.2M | — | |
| 23 | SMMT | Summit Therapeutics Inc. | Healthcare | $10.9B | +2.2% | +0.3% | 6.0M | 🔥 | |
| 24 | CHRS | Coherus Oncology, Inc. | Healthcare | $215.9M | -3.3% | -2.0% | 1.1M | — | red 8-K |
| 25 | CCCC | C4 Therapeutics, Inc. | Healthcare | $431.2M | +2.1% | +5.6% | 3.1M | — | red 8-K |
| 26 | KOD | Kodiak Sciences Inc. | Healthcare | $2.1B | +5.0% | +3.0% | 941K | — | |
| 27 | BCAX | Bicara Therapeutics Inc. | Healthcare | $1.4B | +9.2% | +19.5% | 1.6M | — | |
| 28 | SYRE | Spyre Therapeutics, Inc. | Healthcare | $7.0B | +2.6% | -10.1% | 2.0M | — | red 8-K |
| 29 | MRNA | Moderna, Inc. | Healthcare | $19.8B | +3.6% | +17.4% | 8.1M | 🔥 | |
| 30 | JNJ | JOHNSON & JOHNSON | Healthcare | $579.8B | +1.5% | +11.8% | 8.6M | 🔥 | |
| 31 | CABA | Cabaletta Bio, Inc. | Healthcare | $490.8M | +2.3% | +3.3% | 5.5M | — | |
| 32 | CRBU | Caribou Biosciences, Inc. | Healthcare | $158.2M | +5.4% | +7.9% | 2.8M | — | |
| 33 | WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $205.7M | +6.0% | -1.1% | 364K | — | |
| 34 | SLS | SELLAS Life Sciences Group, Inc. | Healthcare | $1.5B | +24.7% | +81.1% | 33.1M | — | red 8-K |
| 35 | BHVN | Biohaven Ltd. | Healthcare | $1.7B | -5.6% | -3.5% | 3.5M | ⚡ | |
| 36 | STTK | Shattuck Labs, Inc. | Healthcare | $471.8M | +6.4% | +30.7% | 2.0M | — | red 8-K |
| 37 | ERAS | Erasca, Inc. | Healthcare | $4.4B | +14.2% | +21.3% | 8.0M | — | |
| 38 | CBIO | CRESCENT BIOPHARMA, INC. | Healthcare | $494.1M | -3.0% | +2.5% | 432K | — | |
| 39 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | $14.5B | +3.4% | +5.2% | 975K | — | red 8-K |
| 40 | SRRK | Scholar Rock Holding Corp | Healthcare | $5.3B | +0.4% | +11.7% | 2.1M | — | |
| 41 | ALLO | Allogene Therapeutics, Inc. | Healthcare | $655.8M | +4.2% | +5.7% | 14.7M | — | red 8-K |
| 42 | CUE | Cue Biopharma, Inc. | Healthcare | $103.0M | +19.9% | -1.0% | 164K | — | red 8-K |
| 43 | HALO | HALOZYME THERAPEUTICS, INC. | Healthcare | $8.2B | +3.0% | +11.9% | 2.2M | — | red 8-K |
| 44 | INKT | MiNK Therapeutics, Inc. | Healthcare | $59.9M | +2.3% | -2.8% | 14K | — | |
| 45 | VRDN | Viridian Therapeutics, Inc.DE | Healthcare | $1.8B | +5.0% | +6.6% | 7.6M | — | |
| 46 | AVBP | ArriVent BioPharma, Inc. | Healthcare | $1.4B | +1.1% | +5.1% | 486K | — | |
| 47 | AGEN | AGENUS INC | Healthcare | $137.4M | +4.0% | +3.6% | 947K | — | red 8-K |
| 48 | AVTX | Avalo Therapeutics, Inc. | Healthcare | $775.9M | +6.0% | +12.9% | 1.6M | — | red 8-K |
| 49 | RLYB | Rallybio Corp | Healthcare | $92.3M | +0.4% | +0.8% | 31K | — | red 8-K |
| 50 | CLDX | Celldex Therapeutics, Inc. | Healthcare | $2.5B | +6.2% | +12.1% | 1.6M | — | red 8-K |
| 51 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | $603.3M | +0.4% | +3.7% | 1.8M | — | |
| 52 | KLRS | Kalaris Therapeutics, Inc. | Healthcare | $103.0M | -2.4% | -4.2% | 122K | — | red 8-K |
| 53 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | $842.0M | +0.1% | +6.5% | 991K | — | |
| 54 | TIL | Instil Bio, Inc. | Healthcare | $53.7M | +1.4% | -0.4% | 17K | — | red 8-K |
Membership is matched by keyword from companies’ SEC business descriptions (10-K Item 1) — deterministic, not AI inference. May not be exhaustive; not investment advice.